|
1
|
Crowley P, Chalmers I and Keirse MJ: The
effects of corticosteroid administration before preterm delivery:
An overview of the evidence from controlled trials. Br J Obstet
Gynaecol. 97:11–25. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Roberts D and Dalziel S: Antenatal
corticosteroids for accelerating fetal lung maturation for women at
risk of preterm birth. Cochrane Database Syst Rev.
19:CD0044542006.
|
|
3
|
Liggins GC: The role of cortisol in
preparing the fetus for birth. Reprod Fertil Dev. 6:141–150. 1994.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Gross I: Regulation of fetal lung
maturation. Am J Physiol. 259:L337–L344. 1990.PubMed/NCBI
|
|
5
|
Schittny JC, Djonov V, Fine A and Burri
PH: Programmed cell death contributes to postnatal lung
development. Am J Respir Cell Mol Biol. 18:786–793. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Whitsett JA and Stahlman MT: Impact of
advances in physiology, biochemistry and molecular biology on
pulmonary disease in neonates. Am J Respir Crit Care Med.
157:S67–S71. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Walther FJ, Ikegami M, Warburton D and
Polk DH: Corticosteroids, thyrotropin-releasing hormone and
antioxidant enzymes in preterm lamb lungs. Pediatr Res. 30:518–521.
1991. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Pinkerton KE, Willet KE, Peake JL, Sly PD,
Jobe AH and Ikegami M: Prenatal glucocorticoid and T4 effects on
lung morphology in preterm lambs. Am J Respir Crit Care Med.
156:624–630. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Beck JC, Mitzner W, Johnson JW, Hutchins
GM, Foidart JM, London WT, Palmer AE and Scott R: Betamethasone and
the rhesus fetus: Effect on lung morphometry and connective tissue.
Pediatr Res. 15:235–240. 1981. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Vyas J and Kotecha S: Effects of antenatal
and postnatal corticosteroids on the preterm lung. Arch Dis Child
Fetal Neonatal Ed. 77:F147–F150. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wang J, Kuliszewski M, Yee W, Sedlackova
L, Xu J, Tseu I and Post M: Cloning and expression of
glucocorticoid-induced genes in fetal rat lung fibroblasts.
Transforming growth factor-beta 3. J Biol Chem. 270:2722–2728.
1995. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Drake AJ, Walker BR and Seckl JR:
Intergenerational consequences of fetal programming by in utero
exposure to glucocorticoids in rats. Am J Physiol Regul Integr Comp
Physiol. 288:R34–R38. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Drake AJ, Tang JI and Nyirenda MJ:
Mechanisms underlying the role of glucocorticoids in the early life
programming of adult disease. Clin Sci (Lond). 113:219–232. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Yu HR, Kuo HC, Chen CC, Sheen JM, Tiao MM,
Chen YC, Chang KA, Tain YL and Huang LT: Prenatal dexamethasone
exposure in rats results in long-term epigenetic histone
modifications and tumor necrosis factor-α production decrease.
Immunology. 143:651–660. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhang H, Mishra A, Chintagari NR, Gou D
and Liu L: Micro-RNA-375 inhibits lung surfactant secretion by
altering cytoskeleton reorganization. IUBMB Life. 62:78–83.
2010.PubMed/NCBI
|
|
16
|
Lee EK, Lee MJ, Abdelmohsen K, Kim W, Kim
MM, Srikantan S, Martindale JL, Hutchison ER, Kim HH, Marasa BS, et
al: MiR-130 suppresses adipogenesis by inhibiting peroxisome
proliferator-activated receptor gamma expression. Mol Cell Biol.
31:626–638. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Bhaskaran M, Wang Y, Zhang H, Weng T,
Baviskar P, Guo Y, Gou D and Liu L: MicroRNA-127 modulates fetal
lung development. Physiol Genomics. 37:268–278. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Williams AE, Moschos SA, Perry MM, Barnes
PJ and Lindsay MA: Maternally imprinted microRNAs are
differentially expressed during mouse and human lung development.
Dev Dyn. 236:572–580. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Weng T, Mishra A, Guo Y, Wang Y, Su L,
Huang C, Zhao C, Xiao X and Liu L: Regulation of lung surfactant
secretion by microRNA-150. Biochem Biophys Res Commun. 422:586–589.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhang XQ, Zhang P, Yang Y, Qiu J, Kan Q,
Liang HL, Zhou XY and Zhou XG: Regulation of pulmonary surfactant
synthesis in fetal rat type II alveolar epithelial cells by
microRNA-26a. Pediatr Pulmonol. 49:863–872. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Pan CT, Tsai KW, Hung TM, Lin WC, Pan CY,
Yu HR and Li SC: MiRSeq: A user-friendly standalone toolkit for
sequencing quality evaluation and miRNA profiling. Biomed Res Int.
2014:4621352014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Yu HR, Chang JC, Chen RF, Chuang H, Hong
KC, Wang L and Yang KD: Different antigens trigger different
Th1/Th2 reactions in neonatal mononuclear cells (MNCs) relating to
T-bet/GATA-3 expression. J Leukoc Biol. 74:952–958. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Sehgal P, Chaturvedi P, Kumaran RI, Kumar
S and Parnaik VK: Lamin A/C haploinsufficiency modulates the
differentiation potential of mouse embryonic stem cells. PLoS One.
8:e578912013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wang QZ, Xu W, Habib N and Xu R: Potential
uses of microRNA in lung cancer diagnosis, prognosis, and therapy.
Curr Cancer Drug Targets. 9:572–594. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Sessa R and Hata A: Role of microRNAs in
lung development and pulmonary diseases. Pulm Circ. 3:315–328.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Sheng Y, Li J, Zou C, Wang S, Cao Y, Zhang
J, Huang A and Tang H: Downregulation of miR-101-3p by hepatitis B
virus promotes proliferation and migration of hepatocellular
carcinoma cells by targeting Rab5a. Arch Virol. 159:2397–2410.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Li P, Li J, Chen T, Wang H, Chu H, Chang
J, Zang W, Wang Y, Ma Y, Du Y, et al: Expression analysis of serum
microRNAs in idiopathic pulmonary fibrosis. Int J Mol Med.
33:1554–1562. 2014.PubMed/NCBI
|
|
28
|
Hassan F, Nuovo GJ, Crawford M, Boyaka PN,
Kirkby S, Nana-Sinkam SP and Cormet-Boyaka E: MiR-101 and miR-144
regulate the expression of the CFTR chloride channel in the lung.
PLoS One. 7:e508372012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Cho HM, Jeon HS, Lee SY, Jeong KJ, Park
SY, Lee HY, Lee JU, Kim JH, Kwon SJ, Choi E, et al: MicroRNA-101
inhibits lung cancer invasion through the regulation of enhancer of
zeste homolog 2. Exp Ther Med. 2:963–967. 2011.PubMed/NCBI
|
|
30
|
Zhang JG, Guo JF, Liu DL, Liu Q and Wang
JJ: MicroRNA-101 exerts tumor-suppressive functions in non-small
cell lung cancer through directly targeting enhancer of zeste
homolog 2. J Thorac Oncol. 6:671–678. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Sheng Y, Ding S, Chen K, Chen J, Wang S,
Zou C, Zhang J, Cao Y, Huang A and Tang H: Functional analysis of
miR-101-3p and Rap1b involved in hepatitis B virus-related
hepatocellular carcinoma pathogenesis. Biochem Cell Biol.
92:152–162. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Barh D, Malhotra R, Ravi B and Sindhurani
P: MicroRNA let-7: An emerging next-generation cancer therapeutic.
Curr Oncol. 17:70–80. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Johnson SM, Grosshans H, Shingara J, Byrom
M, Jarvis R, Cheng A, Labourier E, Reinert KL, Brown D and Slack
FJ: RAS is regulated by the let-7 microRNA family. Cell.
120:635–647. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Childs G, Fazzari M, Kung G, Kawachi N,
Brandwein-Gensler M, McLemore M, Chen Q, Burk RD, Smith RV,
Prystowsky MB, et al: Low-level expression of microRNAs let-7d and
miR-205 are prognostic markers of head and neck squamous cell
carcinoma. Am J Pathol. 174:736–745. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Schubert M, Spahn M, Kneitz S, Scholz CJ,
Joniau S, Stroebel P, Riedmiller H and Kneitz B: Distinct microRNA
expression profile in prostate cancer patients with early clinical
failure and the impact of let-7 as prognostic marker in high-risk
prostate cancer. PLoS One. 8:e650642013. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Takamizawa J, Konishi H, Yanagisawa K,
Tomida S, Osada H, Endoh H, Harano T, Yatabe Y, Nagino M, Nimura Y,
et al: Reduced expression of the let-7 microRNAs in human lung
cancers in association with shortened postoperative survival.
Cancer Res. 64:3753–3756. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Acunzo M, Romano G, Palmieri D, Laganá A,
Garofalo M, Balatti V, Drusco A, Chiariello M, Nana-Sinkam P and
Croce CM: Cross-talk between MET and EGFR in non-small cell lung
cancer involves miR-27a and Sprouty2. Proc Natl Acad Sci USA.
110:8573–8578. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Wang Q, Li DC, Li ZF, Liu CX, Xiao YM,
Zhang B, Li XD, Zhao J, Chen LP, Xing XM, et al: Upregulation of
miR-27a contributes to the malignant transformation of human
bronchial epithelial cells induced by SV40 small T antigen.
Oncogene. 30:3875–3886. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Kane NM, Howard L, Descamps B, Meloni M,
McClure J, Lu R, McCahill A, Breen C, Mackenzie RM, Delles C, et
al: Role of microRNAs 99b, 181a and 181b in the differentiation of
human embryonic stem cells to vascular endothelial cells. Stem
cells. 30:643–654. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Pan D: Hippo signaling in organ size
control. Genes Dev. 21:886–897. 2007. View Article : Google Scholar : PubMed/NCBI
|
